Efficacy and Safety of Spectacle Lenses With H.A.L.T. MAX Technology on High Myopia Control in Children and Adolescents
Key facts
- Who runs it
- Shanghai Eye Disease Prevention and Treatment Center
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Withdrawn
- Started
- 30 Oct 2026
- Ended
- 30 Oct 2026
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- H.A.L.T. MAX spectacles
- Record updated
- 2 November 2026
- Why it stopped
- Major amendment for protocol
Who can take part
- Age
- 7 years to 14 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- Voluntary, willing to follow the protocol, able to read and understand the information form and give free and informed consent (for parents/guardian of children subjects) and assent (for subjects aged 7-14 years old)
- 7-14 years old,regardless of sex
- Spherical equivalent refraction (SE) after cyclopegia ≤ -5.00 D and ≥ -9.00D
- Anisometropia and Astigmatism ≤2.50D
- Best corrected distance visual acuity of at least 0.8 in both eyes
- Willing to wear only the spectacles provided by the investigator for all days (>10 hours) during the study without additional interventions
- Accept randomization
- Able to sign the informed consent form with the accompaniment and understanding of parents or guardians
Who cannot take part
- Exclude children on high dose atropine (1%) or red light therapy;
- Any previous history of myopia control treatment in the previous 30 days, like low dose atropine, defocus spectacles, or thokeratology and acupuncture;
- Allergic or intolerant to cycloplegic drugs;
- History or presence of an ocular disease, strabismus or amblyopia or other binocular vision abnormalities, accommodation dysfunction, and cataract.;
- History of eye surgery;
- Ocular or systemic diseases that may be associated with myopia, such as Marfan syndrome, retinopathy of newborns, diabetes, etc;
- Other conditions unsuitable for inclusion (patients with excessive expectations for the effect of the defocus spectacle lenses or desires to try other myopia interventions)
- Anatomic or skin factors affecting the wearing of spectacles;
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Children aged 7-14 years with high myopia were randomly assigned to a control group or an intervention group at a 1:1 ratio. The intervention group wore H.A.L.T. MAX lenses for at least 10 hours per day for 2 years, and the control group wore ordinary single-vision (SV) spectacles for at least 10 hours per day. At the 1-year follow-up examination (6-month visit), control subjects whose equivalent spherical diopter change (SER) was ≥0.75 D were switched to H.A.L.T. MAX lenses until the end of year 2. After entering year 2, all remaining control (SV) subjects will be replaced with H.A.L.T. MAX defofocus frames for at least 10 hours per day until the end of year 2. And continue to wear it for at least 10 hours per day. To evaluate the efficacy, safety and compliance of H.A.L.T. MAX lenses in delaying myopia progression in children with high myopia, and to provide a scientific basis for the formulation and practice of public health programs for delaying myopia progression and the risk of blindness and visual impairment caused by high myopia.
The 2 groups in the trial
- the intervention groupTreatment being tested
the intervention group wore H.A.L.T. MAX for at least 10 hours a day for 2 years.
Treatment: H.A.L.T. MAX spectacles
- The control groupNo study treatment, for comparison
The control group will wear single vision lenses (SV) for at least 10 hours a day. In the first year (at 6-month follow-up), study participants in the control group with a spherical equivalent diopter change (SER) of ≥0.75 D will be switched to H.A.L.T. MAX lenses until the end of year 2. After entering year 2, all remaining control (SV) study participants will be replaced with H.A.L.T. MAX spectacles for at least 10 hours per day until the end of year 2.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Efficacy and Safety of Spectacle Lenses With Maximized Highly Aspherical Lenslets Target Technology (H.A.L.T. MAX) on High Myopia Control in Children and Adolescents: a Randomized Controlled Research
- Record updated
- 2 November 2026